Do not Miss Rare and Treatable Cause of Early-Onset Hemolytic Uremic Syndrome: Cobalamin C Deficiency

The most common disorder of vitamin B12 metabolism is methylmalonic aciduria and homocystinuria type cobalamin C (cblC), which accounts for most of the cases is referred to as cblC deficiency. Cobalamin deficiency is one of the causes of early-onset hemolytic uremic syndrome (HUS). Here, we present the cases of 2 infants with cobalamin deficiency who presented with early-onset HUS. The first patient was a 5-month-old female who was admitted to the hospital with seizure, pallor, and yellow-colored diarrheal stools. Initial laboratory examination showed direct Coombs test-negative hemolytic anemia. Later, she developed acute kidney injury and thrombocytopenia. Bone marrow aspiration showed megaloblastic features, and urinary examination showed elevated levels of methylmalonic acid (MMA), methyl citrate, and 3-hydroxypropionic acid. Methionine-restricted diet, parenteral hydroxocobalamine, folinic acid, carnitine, and betaine were initiated. Hemolytic activity was controlled with this treatment. Genetic screening showed homozygous mutation on the MMACHCgene (p.R161*[c.481C>T]). The second patient was a 3-month-old male infant who was admitted to the hospital with malaise and diarrhea. Laboratory examination showed direct Coombs test-negative hemolytic anemia with leukopenia. Later he developed acute kidney injury and thrombocytopenia. Bone marrow aspiration revealed megaloblastic changes. Urine organic acid test showed increased levels of MMA. Parenteral hydroxocobalamine, folinic acid, carnitine, and betaine were initiated. He died due to respiratory failure and cardiac arrest. Direct sequencing of MMACHC identified homozygous mutation, c.271dup A. CblC deficiency is an important cause of early-onset HUS and prompt diagnosis will provide specific treatment modalities.

[1]  K. Frees,et al.  Genetic Analysis of 400 Patients Refines Understanding and Implicates a New Gene in Atypical Hemolytic Uremic Syndrome. , 2018, Journal of the American Society of Nephrology : JASN.

[2]  D. Trevisanuto,et al.  Anemia and transfusion in the neonate. , 2016, Seminars in fetal & neonatal medicine.

[3]  J. Benoist,et al.  Adult-onset renal thrombotic microangiopathy and pulmonary arterial hypertension in cobalamin C deficiency , 2015, The Lancet.

[4]  M. Baumgartner,et al.  Nephrotic syndrome and thrombotic microangiopathy caused by cobalamin C deficiency , 2015, Pediatric Nephrology.

[5]  R. Coppo,et al.  An international consensus approach to the management of atypical hemolytic uremic syndrome in children , 2015, Pediatric Nephrology.

[6]  G. Ardissino,et al.  Discontinuation of eculizumab maintenance treatment for atypical hemolytic uremic syndrome: a report of 10 cases. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[7]  M. Baumgartner,et al.  Clinical presentation and outcome in a series of 88 patients with the cblC defect , 2014, Journal of Inherited Metabolic Disease.

[8]  S. A R,et al.  Role of absolute reticulocyte count in evaluation of pancytopenia-a hospital based study. , 2014, Journal of clinical and diagnostic research : JCDR.

[9]  L. Doucet,et al.  Adult-onset eculizumab-resistant hemolytic uremic syndrome associated with cobalamin C deficiency. , 2014, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[10]  A. Losito,et al.  Combined Pulmonary Hypertension and Renal Thrombotic Microangiopathy in Cobalamin C Deficiency , 2013, Pediatrics.

[11]  A. Iolascon,et al.  Clinical aspects and pathogenesis of congenital dyserythropoietic anemias: from morphology to molecular approach , 2012, Haematologica.

[12]  S. Testa,et al.  Neonatal atypical hemolytic uremic syndrome due to methylmalonic aciduria and homocystinuria , 2012, Pediatric Nephrology.

[13]  K. Hsiao,et al.  Mutation spectrum of MMACHC in Chinese patients with combined methylmalonic aciduria and homocystinuria , 2010, Journal of Human Genetics.

[14]  M. Baumgartner,et al.  Spectrum of mutations in MMACHC, allelic expression, and evidence for genotype–phenotype correlations , 2009, Human mutation.

[15]  G. Uziel,et al.  Spectrum of MMACHC mutations in Italian and Portuguese patients with combined methylmalonic aciduria and homocystinuria, cblC type. , 2008, Molecular genetics and metabolism.

[16]  C. Greenberg,et al.  Hemolytic uremic syndrome (HUS) secondary to cobalamin C (cblC) disorder , 2007, Pediatric Nephrology.

[17]  C. Morel,et al.  Combined methylmalonic aciduria and homocystinuria (cblC): phenotype-genotype correlations and ethnic-specific observations. , 2006, Molecular genetics and metabolism.

[18]  E. Shoubridge,et al.  Identification of the gene responsible for methylmalonic aciduria and homocystinuria, cblC type , 2006, Nature Genetics.

[19]  T. Suormala,et al.  Prenatal and postnatal treatment in cobalamin C defect. , 2005, The Journal of pediatrics.

[20]  P. Francis,et al.  An infant with methylmalonic aciduria and homocystinuria (cblC) presenting with retinal haemorrhages and subdural haematoma mimicking non-accidental injury , 2004, European Journal of Pediatrics.

[21]  T. Kind,et al.  Cobalamin C disease presenting as hemolytic-uremic syndrome in the neonatal period. , 2002, Journal of pediatric hematology/oncology.